10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001683168-22-003503`
Period End Date	20220331
Filing Date	20220512
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	xenetic_i10q-033122_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 24 Cash Flow Statement 26 Stockholders Equity 14

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$18.24M	USD	Point-in-time
Cash	`Cash`	$16.16M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$479.40K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$732.37K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.89M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.72M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.09M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.09M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.47M	shares	Point-in-time
Total assets	`Assets`	$17.98M	USD	Point-in-time
Total assets	`Assets`	$19.82M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.47M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.44M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.44M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$280.68K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$362.47K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$782.59K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$1.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.42M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 13,468,287 and 13,466,603 shares issued as of March 31, 2022 and December 31, 2021, respectively; 13,441,296 and 13,439,612 shares outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$13.46K	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 13,468,287 and 13,466,603 shares issued as of March 31, 2022 and December 31, 2021, respectively; 13,441,296 and 13,439,612 shares outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$13.47K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$205.95M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$206.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-182.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-184.14M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.92M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$18.39M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.22M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.82M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$17.98M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Royalty revenue	`RoyaltyIncomeNonoperating`	$388.99K	USD	1 Quarter
Royalty revenue	`RoyaltyIncomeNonoperating`	$191.22K	USD	1 Quarter
Total revenue	`Revenues`	$388.99K	USD	1 Quarter
Total revenue	`Revenues`	$191.22K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$629.73K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.10M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$930.58K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$907.31K	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.56M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$2.01M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.62M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.37M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$199.00	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$884.00	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$22.26K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$25.91K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$26.10K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$23.15K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Basic and diluted loss per share	`BasicAndDilutedLossPerShare`	$-0.12	USD	1 Quarter
Basic and diluted loss per share	`BasicAndDilutedLossPerShare`	$-0.15	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedaverageSharesOfCommonStockOutstandingBasicAndDiluted`	8.75M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedaverageSharesOfCommonStockOutstandingBasicAndDiluted`	13.44M	shares	1 Quarter

Cash Flow Statement 26 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$8.41K	USD	1 Quarter
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$9.47K	USD	1 Quarter
Share-based expense	`ShareBasedCompensation`	$76.28K	USD	1 Quarter
Share-based expense	`ShareBasedCompensation`	$119.59K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$265.31K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$109.73K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-148.21K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-357.83K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.52M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.09M	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-2.09M	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.52M	USD	1 Quarter
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.01M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.53M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.24M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.16M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.01M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.53M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.24M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.16M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$1.00	USD	1 Quarter
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$2.00	USD	1 Quarter

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$16.92M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$18.39M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$10.95M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$12.22M	USD	Point-in-time
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$119.59K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$76.28K	USD	1 Quarter
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$16.92M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$18.39M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$10.95M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$12.22M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.